| Product Code: ETC7744148 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Oncology NGS Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Oncology NGS Market - Industry Life Cycle |
3.4 Japan Oncology NGS Market - Porter's Five Forces |
3.5 Japan Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Japan Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Japan Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Japan Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Japan Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in Japan |
4.2.2 Technological advancements in next-generation sequencing (NGS) for oncology |
4.2.3 Increasing investments in research and development for personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for NGS in oncology in Japan |
4.3.2 High costs associated with NGS technologies and tests in oncology |
5 Japan Oncology NGS Market Trends |
6 Japan Oncology NGS Market, By Types |
6.1 Japan Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Japan Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Japan Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Japan Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Japan Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Japan Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Japan Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Japan Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Japan Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Japan Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Japan Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Japan Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Japan Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Japan Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Japan Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Japan Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Japan Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Japan Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Japan Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Japan Oncology NGS Market Import-Export Trade Statistics |
7.1 Japan Oncology NGS Market Export to Major Countries |
7.2 Japan Oncology NGS Market Imports from Major Countries |
8 Japan Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in oncology |
8.2 Number of clinical trials utilizing NGS in oncology in Japan |
8.3 Adoption rate of NGS-based treatment protocols in oncology |
9 Japan Oncology NGS Market - Opportunity Assessment |
9.1 Japan Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Japan Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Japan Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Japan Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Japan Oncology NGS Market - Competitive Landscape |
10.1 Japan Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Japan Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here